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The MHC-encoded class II or Ia antigens are highly polymorphic glycoproteins 
consisting of a  heterodimeric structure with an o~ subunit of 33-36,000  kD and 
a 8 subunit of 24-28,000 kD (1). They play an important role in the homeostasis 
of the immune system (2). 
In man there are at least three class II genetic subregions designated DP, DQ, 
DR, each encoding distinct a//3 heterodimers (1, 3, 4). 
Control of Ia antigen expression at  the cell surface, in addition  to polymor- 
phism and heterogeneity, influences the role of class II antigens in the regulation 
of the immune response (5). 
We  recently described a  human  B  cell variant,  RJ  2.2.5,  derived from  Raji 
cells after mutagenesis and immunoselection with anti-Ia mAb (6). The RJ 2.2.5 
cells express none of the class II antigens (6), as shown by a  lack of specific class 
II mRNAs (7, 8). The class II-positive phenotype of RJ 2.2.5 cells can be restored 
in somatic cell hybrids between this variant and mouse B lymphoma cells (8) or 
mouse spleen cells (9).  Phenotypic and structural studies have indicated that in 
these hybrids a mouse factor, unlinked to MHC products, is acting as an activator 
that positively regulates the expression of both mouse and man class II genes (9). 
Karyotypic analysis and segregation studies  in an informative family of hybrids 
have now permitted us to assign the locus of this trans-acting activator for class 
II genes to mouse chromosome 16. 
Materials and Methods 
Somatic Cell Hybrids.  In previous reports, we have described the derivation of the RJ 
2.2.5 Ia- variant (6) and of RJ 2.2.5 x  mouse spleen cell hybrids (9) used in this study. 
Selection of the hybrids on the basis of the presence or absence of a relevant MHC antigen 
on the cell surface was carried out on a  FACS II (Becton Dickinson Immunocytometry 
Systems, Mountain View, Ca) after indirect immunofluorescence staining of the cells with 
specific mAbs (see legend to Fig.  1), as reported (9). 
Karyotype Analysis.  The karyotype of the various cell lines described in this study was 
analyzed after metaphase chromosome preparation and staining by G-banding following 
standard procedures. 
DNA Analysis.  Genomic DNA from the various cell lines  was extracted as described 
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previously (8). After digestion with Hind III, the DNA was separated on a 0.7% agarose 
gel, transferred to Gene Screen Plus hybridization transfer membranes (Amersham Corp., 
Buckinghamshire, United Kingdom), and hybridized with an c~-[32p]dNTP-labeled mouse 
Vkl probe, pc Vkl, derived from the genomic VM clone described in reference  ! 1, and 
kindly donated by Dr. S. Weiss (Basel Institute for hnmunology, Switzerland). The filters 
were washed in stringent conditions according to the specification of the manufacturers, 
and they were exposed to X-OMAT Kodak films  for 10 d at -80°C. 
Results and Discussion 
To  assign  the  locus  encoding the  trans-acting  factor (activator  of immune 
response genes-locus  1 lair-l])  to a  specific mouse chromosome we selected a 
series  of RJ  2.2.5  ×  mouse spleen  cell  hybrids (9)  with  specified phenotypic 
characteristics.  In  one  clone,  designated  A2-2.4  c.6  (similar  to  clone  c.9  in 
reference 9),  human HLA class  I (A,B,C) antigens were expressed in  100%  of 
the cells; human class II antigens of the DR subset were expressed in 90% of the 
cells.  In a  second class II subset, the DQ antigen was expressed in 87%  of the 
cells (data not shown). Mouse H-2 class I (H-2K) and class II (I-A) antigens were 
expressed in 50% of the cells (see Fig. 1A). 
A2-2.4 c.6 cells had a modal chromosome number of 93-94.  A pseudotetra- 
ploidy of the human genome was found, with a number of chromosomes ranging 
between 91  and 93.  The parental RJ  2.2.5  human Ia- cells  presented a  chro- 
mosome number of 46, with various chromosome abnormalities including t(8; 14) 
and trisomy 7 (data not shown), frequently found in human Burkitt lymphoma 
lines (10).  The human pseudotetraploidy of A2.2-4  c.6  probably arose  by an 
accidental tri-parental mating, as suggested by the fact that all clones derived 
from the hybrid A2 exhibited similar human chromosome complement. Analysis 
of a  large number of metaphases of A2-2.4  c.6 cells  (see  Fig.  1)  revealed the 
presence of two mouse chromosomes, namely the 17 and a second chromosome, 
which  by  cytogenetic characteristics  was  identical  to  mouse  chromosome  16 
except for a small deletion of part of its distal region (band C3 and probably part 
of C2 and C4) (see  Fig.  1 B, top). The assignment was confirmed by Southern 
blot  hybridization with a  probe  specific for the  V3,1 Ig gene (11)  located on 
mouse chromosome 16 (12, see below). Karyotyping of A2-2.4 c.6 cells showed 
that mouse chromosome 17 was present in 50% of the metaphases analyzed, in 
agreement with the proportion of cells  actually displaying mouse MHC class  I 
antigens on  the cell surface. Mouse chromosome 16  was found in 86%  of the 
metapbases analyzed, in  agreement with  the  proportion  of cells  reexpressing 
human class  II  antigens in the clone hybrid. These results suggested that the 
presence of mouse chromosome 16 correlated with the presence of the class  II 
gene-activator trans-acting factor. To better demonstrate this point, we used the 
FACS to separate the A2-2.4 c.6 population into two fractions on the basis of a 
DR  + and DR- phenotype, respectively. The cells from each fraction were first 
expanded by in vitro culture and then karyotyped. The results of such analysis 
are reported in Fig. 1. At the time of karyotyping  the DR+-selected cells expressed 
the following cell surface MHC phenotypes: HLA, A,B,C,  100%;  DR, 91%; H- 
2K,  23%;  I-A,  25%.  Accordingly, mouse chromosome 16  was present  in  92% 
and mouse chromosome 17  in  24%  of the metaphases analyzed. DR--selected 
cells expressed the following cell surface MHC phenotypes: HLA A,B,C, 100%; 
DR,  2%;  H-2K,  13%.  Accordingly, mouse chromosome  16  was present in  3% ACCOLLA  ET  AL.  BRIEF  DEFINITIVE  REPORT  371 
FIGURE  1.  (A) MHC phenotype and corresponding mouse chromosomes found in informa- 
tive RJ 2.2.5 x  mouse spleen cell hybrids. The MHC phenotype of the hybrids listed on the 
top of each panel was assessed by indirect immunofluorescence with specific mAbs and FACS. 
(a)  HLA-A,B,C (mAb B9.12.1  [14]);  (b)  DR (mAb Dl-12  [3]);  (c) H-2K (mAb S13.11  [15]); 
(d) I-A (mAb 25.9.17  [16]).  Results are expressed as percent positive cells (ordinate). For each 
hybrid  40-60  metaphases  were analyzed and  the  number  of metaphases  with  the  specific 
mouse chromosomes (16,  17, and 3) listed on the abscissa  was expressed as percent of the total 
number analyzed (ordinate).  (B) Aspect of metaphase  mouse chromosomes  16,  17, and 3 (G- 
banding)  as found  in  the  various hybrids analyzed in this study.  When  present (see A),  the 
chromosome 16 in A2-derived hybrids (upper panel) presented a small deletion (arrow) of the 
distal region (band C3, and probably part of C2 and C4), in contrast to the canonic chromosome 
16 found in H4-derived hybrids (lower panel). A schematic representation of mouse chromo- 
some 16 is also reported in both panels for comparison. 
and  mouse chromosome  17  in  11%  of the  metaphases  analyzed.  These  results 
were  further corroborated  by  DNA analysis  of the two distinct  hybrid popula- 
tions.  Hybridization  with  the  mouse  V?,I  probe  was  clearly  positive  with  the 
DR+-selected  cells  (Fig.  2b),  whereas  no  hybridization  was  observed  with  the 
DR--selected  cells  (Fig.  2c).  Therefore,  segregation  of mouse chromosome  16 
was accompanied  by  the  loss of reexpressibility  of human class  I!  genes  in  the 
A2-2.4 c.6 hybrid. 
The  association  of  mouse  chromosome  16  with  the  reexpressibility  of  the 
human class II genes was further documented by the analysis of two other clones, 
one of which,  A2-KD,  was derived  from  the same  original  A2  hybrid  (9) after 
selection for H-2K + cells and further cloning by limiting dilution technique; the 372  ACCOLLA  ET  AL.  BRIEF  DEFINITIVE  REPORT 
FIGURE  2.  Presence of a mouse chromosome 16 marker in various hybrids and parental cell 
lines as detected by Southern blot hybridization with an Ig VM  probe. (a) RJ 2.2.5 DNA; (b) 
DNA from a  FACS-enriched DR  + population from A2-2.4 c.6 presenting chromosome 16 in 
its karyotype; (c) DNA from a FACS-enriched DR- population from A2-2.4 c.6 not containing 
chromosome  16  in  its karyotype;  (d)  DNA  from  A2-KD, a  DR- derivative of A2;  (e)  DNA 
from M 12,4.1, a mouse B cell lymphoma line. 
second clone, designated H4,  originated from a  distinct hybrid selected early 
after fusion of RJ 2.2.5 and mouse spleen cells.  Interestingly, the A2-KD clone 
did not express either human or mouse class II gene products, although human 
class I was expressed in  100% of the cells and mouse H-2K in 74% of the cells 
(Fig.  1  a). 
Karyotype analysis of A2-KD clone revealed the presence of a  single mouse 
chromosome, namely chromosome 17 (Fig.  1, A and B), in 76% of the cells;  it 
also revealed the pseudotetraploidy of human chromosomes already observed 
for the A2-2.4 c.6 hybrid cells.  As expected, Southern blot hybridization exper- 
iments revealed no hybridization of the probe  containing the  V~I  gene  with 
DNA prepared from A2-KD cloned cells (Fig. 2 d). 
The second hybrid, namely H4,  displayed an  MHC  cell  surface phenotype 
consisting of: HLA-A,B,C, 100%; DR, 42%; H-2K, 1%; I-A, 1% (data not shown). 
As for A2.2-4 c.6 hybrid, H4 cells were selected with the FACS on the basis  of 
DR  + and DR- phenotype, and then karyotyped. Interestingly, both H4 popula- 
tions had the same human ploidy as RJ 2.2.5  cells  (46 chromosomes, data not 
shown). Two mouse chromosomes were detectable by karyotyping, the  16 and 
the  3  (Fig.  1,  A and B,  bottom). In  contrast to  A2-derived hybrids, a  canonic 
mouse chromosome 16  was present in the H4 hybrid. The presence of mouse 
chromosome 3  correlated with the ouabain-resistance selection (13)  originally 
adopted to select for hybrids after RJ  2.2.5  ×  mouse spleen cell fusion (9).  In 
the DR  + (85%) population, chromosome 16 was present in 89% and chromosome 
3 in 70% of the metaphases analyzed. In the DR- population, chromosome 16 
was never found, whereas chromosome 3 was found in 30% of the metaphases 
analyzed (Fig.  1A).  These  results  confirmed the  exclusive  association  of the 
human Ia  + phenotype with the presence of mouse chromosome 16. 
Taken together, the results presented in this report show that the presence of 
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is a  necessary and sufficient condition to allow expression of both mouse and 
human class  II genes. We establish the existence of a newly found locus, air-l, 
that  is  located  in  this  chromosome  and  determines  a  trans-acting  activator 
function. Within this frame, the class  II-negative phenotype in  RJ  2.2.5  cells 
may thus be interpreted as originating from a lesion in the human equivalent of 
the  air-1  locus  coding  for,  or  affecting  the  expression  of,  the  trans-acting 
regulatory factor. 
The  fact  that  a  recessive  lesion  in  a  seemingly autosomal  locus  could  be 
expressed in RJ 2.2.5 cells suggests either that these cells carry a double mutation 
at the alr-I  locus-equivalent or that only one allele of this regulatory gene is 
normally functional in  B  cells.  In  the latter case,  the other copy of the gene 
might be kept silent by allelic exclusion or a  similar mechanism. In the former 
case, the two mutations could be cogenerated at the same time when Raji cells 
were mutagenized to obtain the RJ 2.2.5 variant (6), or alternatively, Raft cells 
used for mutagenesis could contain only one functional copy of the regulatory 
locus  because  of a  previous  independent  mutational  event  that  removed  or 
inactivated one of the two alleles. The occurrence of chromosomal rearrange- 
ments in  Burkitt lymphomas (10)  may have some bearing on this point.  The 
possibility that a gene dosage mechanism may be responsible for the phenotype 
of RJ 2.2.5 cells seems less likely in view of the fact that, as proven by karyotype 
analysis, one copy of chromosome 16 was sufficient to allow reexpression of both 
mouse and human class II genes. 
The discovery of the alr-1 locus and its assignment to mouse chromosome 16 
will stimulate further efforts to isolate and clone the corresponding gene. This 
will  in  turn permit a  biochemical characterization of the gene product and a 
detailed analysis of its mode of action. Moreover, the assessment of the role of 
this trans-acting factor in the developmental regulation of the expression of class 
II genes and of its influence on the functions mediated by class II gene products 
will be greatly facilitated. 
Summary 
RJ 2.2.5 is a human B cell line that has lost the capacity to express MHC class 
II  genes.  The  human  class  II-positive  phenotype is  restored  in  somatic  cell 
hybrids between RJ 2.2.5 and mouse spleen cells. 
By karyotype and molecular studies of an informative family of hybrids we 
have now shown that the reexpression of human class II gene products, as well 
as the maintenance of the mouse class II-positive phenotype, correlates with the 
presence of mouse chromosome 1(5. Thus, the existence on this mouse chromo- 
some of a  newly found locus, designated by us Mr-l,  that determines a  trans- 
acting activator  function for class  II  gene  expression,  is  established.  Possible 
implications of this finding are discussed. 
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